Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 8

P-wave indices in patients with pulmonary emphysema: do P-terminal force and interatrial block have confounding effects?

Authors Chhabra L, Chaubey VK, Kothagundla C, Bajaj R, Kaul S, Spodick DH

Received 12 March 2013

Accepted for publication 12 April 2013

Published 14 May 2013 Volume 2013:8 Pages 245—250

DOI http://dx.doi.org/10.2147/COPD.S45127

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Lovely Chhabra,1 Vinod K Chaubey,1 Chandrasekhar Kothagundla,1 Rishi Bajaj,1 Sudesh Kaul,1 David H Spodick2

1Department of Internal Medicine, 2Department of Cardiovascular Diseases, University of Massachusetts Medical School, Worcester, MA, USA

Introduction: Pulmonary emphysema causes several electrocardiogram changes, and one of the most common and well known is on the frontal P-wave axis. P-axis verticalization (P-axis > 60°) serves as a quasidiagnostic indicator of emphysema. The correlation of P-axis verticalization with the radiological severity of emphysema and severity of chronic obstructive lung function have been previously investigated and well described in the literature. However, the correlation of P-axis verticalization in emphysema with other P-indices like P-terminal force in V1 (Ptf), amplitude of initial positive component of P-waves in V1 (i-PV1), and interatrial block (IAB) have not been well studied. Our current study was undertaken to investigate the effects of emphysema on these P-wave indices in correlation with the verticalization of the P-vector.
Materials and methods: Unselected, routinely recorded electrocardiograms of 170 hospitalized emphysema patients were studied. Significant Ptf (s-Ptf) was considered ≥40 mm.ms and was divided into two types based on the morphology of P-waves in V1: either a totally negative (-) P wave in V1 or a biphasic (+/-) P wave in V1.
Results: s-Ptf correlated better with vertical P-vectors than nonvertical P-vectors (P = 0.03). s-Ptf also significantly correlated with IAB (P = 0.001); however, IAB and P-vector verticalization did not appear to have any significant correlation (P = 0.23). There was a very weak correlation between i-PV1 and frontal P-vector (r = 0.15; P = 0.047); however, no significant correlation was found between i-PV1 and P-amplitude in lead III (r = 0.07; P = 0.36).
Conclusion: We conclude that increased P-tf in emphysema may be due to downward right atrial position caused by right atrial displacement, and thus the common assumption that increased P-tf implies left atrial enlargement should be made with caution in patients with emphysema. Also, the lack of strong correlation between i-PV1 and P-amplitude in lead III or vertical P-vector may suggest the predominant role of downward right atrial distortion rather than right atrial enlargement in causing vertical P-vector in emphysema.

Keywords: P-terminal force, interatrial block, emphysema, vertical P-vector, P-axis, left atrial enlargement

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 

 

Other articles by this author:

Diagnostic electrocardiographic dyad criteria of emphysema in left ventricular hypertrophy

Lanjewar SS, Chhabra L, Chaubey VK, Joshi S, Kulkarni G, Kothagundla C, Kaul S, Spodick DH

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:591-594

Published Date: 22 November 2013

Optimal electrocardiographic limb lead set for rapid emphysema screening

Bajaj R, Chhabra L, Basheer Z, Spodick DH

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:41-44

Published Date: 19 January 2013

Readers of this article also read:

Accessing to the minor proteome of red blood cells through the influence of the nanoparticle surface properties on the corona composition

Zaccaria A, Roux-Dalvai F, Bouamrani A, Mombrun A, Mossuz P, Monsarrat B, Berger F

International Journal of Nanomedicine 2015, 10:1869-1883

Published Date: 9 March 2015

The effect of comorbidities on COPD assessment: a pilot study

Weinreich UM, Thomsen LP, Bielaska B, Jensen VH, Vuust M, Rees SE

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:429-438

Published Date: 25 February 2015

Anti-MTG16 antibodies reveal MTG16 subcellular distribution and nucleocytoplasmic transport in erythroleukemia cells

Nguyen H, Mariotti J, Bareyan D, Carnahan RH, Cooper T, Williams CS, Engel ME

Antibody Technology Journal 2015, 5:27-41

Published Date: 19 February 2015

High molecular weight chitosan derivative polymeric micelles encapsulating superparamagnetic iron oxide for tumor-targeted magnetic resonance imaging

Xiao Y, Lin ZT, Chen Y, Wang H, Deng YL, Le DE, Bin J, Li M, Liao Y, Liu Y, Jiang GB, Bin J

International Journal of Nanomedicine 2015, 10:1155-1172

Published Date: 5 February 2015

Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance

El-Helou N, Al-Hajje A, Ajrouche R, Awada S, Rachidi S, Zein S, Salameh P

Vascular Health and Risk Management 2013, 9:81-88

Published Date: 1 March 2013

A new approach to the treatment of recurrent aphthous stomatitis with bioadhesive gels containing cyclosporine A solid lipid nanoparticles: in vivo/in vitro examinations

Karavana SY, Gökçe EH, Rençber S, Özbal S, Pekçetin Ç, Güneri P, Ertan G

International Journal of Nanomedicine 2012, 7:5693-5704

Published Date: 9 November 2012

Advances in the diagnosis and management of lymphoma

Word ZH, Matasar MJ

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:29-55

Published Date: 3 February 2012

Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery

Lian H, Sun J, Yu YP, Liu YH, Cao W, Wang YJ, Sun YH, Wang SL, He ZG

International Journal of Nanomedicine 2011, 6:3323-3334

Published Date: 12 December 2011

Gout disease-specific quality of life and the association with gout characteristics

Jan D Hirsch, Robert Terkeltaub, Dinesh Khanna, et al

Patient Related Outcome Measures 2010, 1:1-8

Published Date: 31 March 2010

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom

Peter Layer, Jutta Keller, Helena Loeffler, Andreas Kreiss

Therapeutics and Clinical Risk Management 2007, 3:107-118

Published Date: 15 March 2007